Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Patient Reported Outcomes in Pulmonary Arterial Hypertension (PROPAH)

This study has been withdrawn prior to enrollment.
Sponsor:
Collaborators:
University of Chicago
Mayo Clinic
Vanderbilt University
Information provided by (Responsible Party):
Pfizer
ClinicalTrials.gov Identifier:
NCT01792622
First received: February 7, 2013
Last updated: July 31, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: September 2013
  Estimated Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)